Compare WTTR & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WTTR | TMDX |
|---|---|---|
| Founded | 2016 | 1998 |
| Country | United States | United States |
| Employees | 3300 | N/A |
| Industry | Oilfield Services/Equipment | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.6B |
| IPO Year | 2017 | 2019 |
| Metric | WTTR | TMDX |
|---|---|---|
| Price | $20.27 | $88.07 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 9 |
| Target Price | $16.67 | ★ $148.22 |
| AVG Volume (30 Days) | ★ 1.3M | 622.5K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.65% | N/A |
| EPS Growth | N/A | ★ 382.18 |
| EPS | N/A | ★ 0.61 |
| Revenue | ★ $1,528,930,000.00 | $605,494,000.00 |
| Revenue This Year | $2.11 | $24.25 |
| Revenue Next Year | $4.94 | $18.75 |
| P/E Ratio | ★ $69.16 | $143.10 |
| Revenue Growth | ★ 120.79 | 37.13 |
| 52 Week Low | $9.29 | $60.11 |
| 52 Week High | $22.55 | $156.00 |
| Indicator | WTTR | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 49.79 | 53.39 |
| Support Level | $17.61 | $80.29 |
| Resistance Level | $20.27 | $90.67 |
| Average True Range (ATR) | 0.66 | 4.05 |
| MACD | 0.01 | -0.24 |
| Stochastic Oscillator | 42.84 | 76.84 |
Select Water Solutions Inc provides sustainable water-management solutions to the energy industry in the United States. These solutions are supported by the company's critical water infrastructure assets, chemical manufacturing, and water treatment and recycling capabilities. The company's reportable segments are Water Services, Water Infrastructure, and Chemical Technologies. It generates maximum revenue from the Water Services segment, which comprises its short-cycle, field-based service offerings, including water transfer, water sourcing, fluids hauling, monitoring, containment, water-network automation, and the services associated with Peak Rentals. This segment earns revenue via market-based day rates, time-and-materials, or per-barrel delivered under MSAs and short-term work orders.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.